Anfield Capital Management, LLC Edwards Lifesciences Corp Transaction History

Anfield Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $3,699 - $4,873	51 New	51 $4,000
Q4 2021 Feb 03, 2022	SELL	$106.37 - $130.68 $11,168 - $13,721	-105 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$102.91 - $122.75 $10,805 - $12,888	105 New	105 $12,000
Q1 2020 May 07, 2020	SELL	$52.41 - $81.0 $55,973 - $86,508	-1,068 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $76,575 - $87,672	1,068 New	1,068 $247,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.